![61718-80-7-5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone.jpg](https://ecdn6-nc.globalso.com/upload/p/2809/image_product/2024-12/61718-80-7-5-methoxy-1-4-trifluoromethyl-phenyl-1-pentanone.jpg)
![5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone-61718-80-7.jpg](https://ecdn6-nc.globalso.com/upload/p/2809/image_product/2024-12/5-methoxy-1-4-trifluoromethyl-phenyl-1-pentanone-61718-80-7.jpg)
5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone
Basic information
Product Name: 5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone
Synonyms:
CAS: 61718-80-7
MF: C13H15F3O2
MW: 260.25
Chemical Properties
Boiling Point: 318.7±42.0 °C(Predicted)
Density: 1.147±0.06 g/cm3(Predicted)
storage temp: Sealed in dry,Room Temperature
Solubility: Chloroform (Slightly), Methanol (Slightly)
Form: NA
Pka: NA
Color: NA
InChI: NA
InChIKey: NA
SMILES: NA
product description
Synthesis of antimicrobial drugs: As a prodrug of tedizolid, tedizolid phosphate can be rapidly converted into biologically active tedizolid by phosphatase in vivo for the treatment of acute bacterial skin tissue infection in adults caused by gram-positive bacteria.
Scientific research reagents: widely used in molecular biology, pharmacology and other scientific research fields, is an indispensable reagent in scientific research, but it is strictly forbidden to use it in the human body.
Pharmacokinetic studies: In clinical trials, the pharmacokinetic profile of tedizolid phosphate is studied to evaluate its efficacy and safety in treatment.
Antimicrobial activity study: Tedizolid phosphate also has strong in vitro antibacterial activity against some vancomycin and linezolid-resistant strains, providing a new option against drug-resistant strains.
Treatment of acute bacterial skin and skin soft tissue infections (ABSSSI): Tedizolid phosphate is indicated for the treatment of ABSSSI caused by susceptible strains, including infections caused by methicillin-resistant Staphylococcus aureus (MRSA).
Drug Interaction Studies: Compared with linezolid, tedizolid phosphate does not exhibit similar drug-drug interactions, providing patients with a safer treatment option.
Antimicrobial drug development: As a new oxazolidinone antibiotic, tedizolid phosphate has the advantages of strong antibacterial activity, high oral bioavailability and long half-life, and is an ideal antibacterial drug.